Skip to main content
TipRanks
Go Ultimate75% OFF

Krsnaa Diagnostics Limited (KRSNAA) Stock Price & Analysis

1 Followers

KRSNAA Stock Chart & Stats

₹518.60₹4.20(0.82%)
At close: 3:30 PM GMT+5:30
₹475₹500₹525₹550Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
INR 510.10 - INR 523.85
52-Week Range
INR 462.10 - INR 834.90
Previous Close
INR 514.40
Volume
N/A
Average Volume (3M)
5,522
Market Cap
INR 16.69B
Enterprise Value
INR 22.30B
Total Cash (Recent Filing)
INR 1.92B
Total Debt (Recent Filing)
INR 5.96B
Price to Earnings (P/E)
17.2
Beta
0.66
Next Earnings
Feb 14, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
0.39%

Bulls Say, Bears Say

Bulls Say

Consistent Revenue Growth

Consistent revenue expansion indicates sustained demand for Krsnaa Diagnostics’ pathology and radiology services. Continued top-line growth can increase network utilization, strengthen its position in institutional healthcare delivery, and provide a durable base for operating leverage over the next several quarters.

Deleveraged Balance Sheet

Lower leverage and declining total debt improve financial flexibility and reduce the balance-sheet burden associated with expansion. A sizable equity base gives the company more capacity to support diagnostic infrastructure investment and absorb operating volatility without relying as heavily on external funding.

Positive Operating Cash Flow

Positive operating cash flow across the reported period shows that the core diagnostic operations generate cash before capital investment. This supports ongoing service delivery and provides an internal funding source, even though the company still faces substantial investment and working-capital demands.

Bears Say

Persistent Negative Free Cash Flow

Repeatedly negative free cash flow indicates that operating cash generation has not consistently covered capital investment and other cash requirements. This can constrain self-funded expansion, increase dependence on balance-sheet capacity, and make future growth more sensitive to funding availability.

Volatile Profitability

The sharp margin deterioration in 2024 followed by recovery shows that earnings performance and the cost structure have not been consistently stable. Such volatility makes future profit conversion less predictable and may weaken the durability of returns even while revenue continues to grow.

Inconsistent Cash Conversion

Weak and inconsistent conversion of reported profits into cash reduces the quality and flexibility of earnings. It may leave less internally generated funding for diagnostic-center expansion, increase reliance on available financing, and make accounting performance less representative of spendable cash resources.

Krsnaa Diagnostics Limited News

KRSNAA FAQ

What was Krsnaa Diagnostics Limited’s price range in the past 12 months?
Krsnaa Diagnostics Limited lowest stock price was ₹462.10 and its highest was ₹834.90 in the past 12 months.
What is Krsnaa Diagnostics Limited’s market cap?
Krsnaa Diagnostics Limited’s market cap is ₹16.69B.
When is Krsnaa Diagnostics Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Krsnaa Diagnostics Limited’s earnings last quarter?
Krsnaa Diagnostics Limited released its earnings results on Nov 02, 2026. The company reported ₹8 earnings per share for the quarter, beating the consensus estimate of ₹6.35 by ₹1.65.
Is Krsnaa Diagnostics Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Krsnaa Diagnostics Limited pay dividends?
Krsnaa Diagnostics Limited pays an annual dividend of ₹2 which represents an annual dividend yield of 0.39%. See more information on Krsnaa Diagnostics Limited dividends here
What is Krsnaa Diagnostics Limited’s EPS estimate?
Krsnaa Diagnostics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Krsnaa Diagnostics Limited have?
Krsnaa Diagnostics Limited has 32,438,670 shares outstanding.
What happened to Krsnaa Diagnostics Limited’s price movement after its last earnings report?
Krsnaa Diagnostics Limited reported an EPS of ₹8 in its last earnings report, beating expectations of ₹6.35. Following the earnings report the stock price went up 2.341%.
Which hedge fund is a major shareholder of Krsnaa Diagnostics Limited?
Currently, no hedge funds are holding shares in IN:KRSNAA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology